The TIMP Protein Family: Diverse Roles in Pathophysiology

Overview

Journal Am J Physiol Cell Physiol

Publisher American Physiological Society

Specialties Cell Biology
Physiology

Date 2024 Jan 29

PMID 38284123

Authors

Sasha Coates-Park

Joshua A Rich

William G Stetler-Stevenson

David Peeney

Affiliations

Soon will be listed here.

Abstract

The tissue inhibitors of matrix metalloproteinases (TIMPs) are a family of four matrisome proteins classically defined by their roles as the primary endogenous inhibitors of metalloproteinases (MPs). Their functions however are not limited to MP inhibition, with each family member harboring numerous MP-independent biological functions that play key roles in processes such as inflammation and apoptosis. Because of these multifaceted functions, TIMPs have been cited in diverse pathophysiological contexts. Herein, we provide a comprehensive overview of the MP-dependent and -independent roles of TIMPs across a range of pathological conditions. The potential therapeutic and biomarker applications of TIMPs in these disease contexts are also considered, highlighting the biomedical promise of this complex and often misunderstood protein family.

Citing Articles

Advancements and future directions in : a 2024 editorial update.

Schaefer L Am J Physiol Cell Physiol. 2024; 327(6):C1681-C1685.

PMID: 39651915 PMC: 11684871. DOI: 10.1152/ajpcell.00862.2024.

Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL).

Peeney D, Gurung S, Rich J, Coates-Park S, Liu Y, Toor J J Proteome Res. 2024; 23(10):4715-4728.

PMID: 39238192 PMC: 11460327. DOI: 10.1021/acs.jproteome.4c00606.

Mechanisms of assembly and remodelling of the extracellular matrix.

Naba A Nat Rev Mol Cell Biol. 2024; 25(11):865-885.

PMID: 39223427 DOI: 10.1038/s41580-024-00767-3.

Three-dimensional cell culture conditions promoted the Mesenchymal-Amoeboid Transition in the Triple-Negative Breast Cancer cell line MDA-MB-231.

Rodriguez-Cruz D, Boquet-Pujadas A, Lopez-Munoz E, Rincon-Heredia R, Paredes-Diaz R, Flores-Fortis M Front Cell Dev Biol. 2024; 12:1435708.

PMID: 39156975 PMC: 11327030. DOI: 10.3389/fcell.2024.1435708.

References

Peeney D, Liu Y, Lazaroff C, Gurung S, Stetler-Stevenson W . Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer. Carcinogenesis. 2022; 43(5):405-418. PMC: 9167030. DOI: 10.1093/carcin/bgac037. View

Lizarraga F, Espinosa M, Ceballos-Cancino G, Vazquez-Santillan K, Bahena-Ocampo I, Schwarz-Cruz Y Celis A . Tissue inhibitor of metalloproteinases-4 (TIMP-4) regulates stemness in cervical cancer cells. Mol Carcinog. 2015; 55(12):1952-1961. DOI: 10.1002/mc.22442. View

Apparailly F, Noel D, Millet V, Baker A, Lisignoli G, Jacquet C . Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis. Arthritis Rheum. 2001; 44(6):1444-54. DOI: 10.1002/1529-0131(200106)44:6<1444::AID-ART240>3.0.CO;2-Q. View

Sounni N, Rozanov D, Remacle A, Golubkov V, Noel A, Strongin A . Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells. Int J Cancer. 2009; 126(5):1067-78. PMC: 2864114. DOI: 10.1002/ijc.24690. View

Nagase H . Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res. 1998; 8(3):179-86. DOI: 10.1038/cr.1998.18. View

Arvidsson M, Ahmed A, Saleby J, Hesselstrand R, Radegran G . Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension. Pulm Circ. 2022; 12(1):e12041. PMC: 9053005. DOI: 10.1002/pul2.12041. View

Culpitt S, Rogers D, Traves S, Barnes P, Donnelly L . Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med. 2005; 99(6):703-10. DOI: 10.1016/j.rmed.2004.10.022. View

Sun J, Bao J, Shi Y, Zhang B, Yuan L, Li J . Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model. Int J Chron Obstruct Pulmon Dis. 2017; 12:717-724. PMC: 5327908. DOI: 10.2147/COPD.S110520. View

Vandenbroucke R, Libert C . Is there new hope for therapeutic matrix metalloproteinase inhibition?. Nat Rev Drug Discov. 2014; 13(12):904-27. DOI: 10.1038/nrd4390. View

10.

Kumar N, Moideen K, Nancy A, Viswanathan V, Thiruvengadam K, Sivakumar S . Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis. JAMA Netw Open. 2020; 3(12):e2027754. PMC: 7709089. DOI: 10.1001/jamanetworkopen.2020.27754. View

11.

Hao W, Li M, Zhang C, Zhang Y, Wang P . Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients. Immunopharmacol Immunotoxicol. 2019; 41(2):224-230. DOI: 10.1080/08923973.2019.1609496. View

12.

Escalona R, Bilandzic M, Western P, Kadife E, Kannourakis G, Findlay J . TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells. BMC Cancer. 2020; 20(1):960. PMC: 7542139. DOI: 10.1186/s12885-020-07274-6. View

13.

Cunningham L, Wetzel M, Rosenberg G . Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia. 2005; 50(4):329-339. DOI: 10.1002/glia.20169. View

14.

Britton R, Wasley T, Harish R, Holz C, Hall J, Yee D . Noncanonical Activity of Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Improves Cognition and Synapse Density in Aging. eNeuro. 2023; 10(6). PMC: 10275401. DOI: 10.1523/ENEURO.0031-23.2023. View

15.

Daubin D, Cristol J, Dupuy A, Kuster N, Besnard N, Platon L . Urinary Biomarkers IGFBP7 and TIMP-2 for the Diagnostic Assessment of Transient and Persistent Acute Kidney Injury in Critically Ill Patients. PLoS One. 2017; 12(1):e0169674. PMC: 5234791. DOI: 10.1371/journal.pone.0169674. View

16.

Bigelow R, Williams B, Carroll J, Daves L, Cardelli J . TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro. Breast Cancer Res Treat. 2008; 117(1):31-44. DOI: 10.1007/s10549-008-0170-7. View

17.

Black R, Durie F, Miller R, Slack J, Lynch D, Castner B . Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP. Biochem Biophys Res Commun. 1996; 225(2):400-5. DOI: 10.1006/bbrc.1996.1186. View

18.

Bachman K, Herman J, Corn P, Merlo A, Costello J, Cavenee W . Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res. 1999; 59(4):798-802. View

19.

Vanhoutte D, Heymans S . TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'. J Mol Cell Cardiol. 2009; 48(3):445-53. DOI: 10.1016/j.yjmcc.2009.09.013. View

20.

Sharifi M, Wierer M, Dang T, Milic J, Moggio A, Sachs N . ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1. Circ Res. 2023; 133(8):674-686. PMC: 7615141. DOI: 10.1161/CIRCRESAHA.123.322737. View